SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-035879
Filing Date
2022-06-10
Accepted
2022-06-10 16:20:27
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4282
  Complete submission text file 0001209191-22-035879.txt   5657
Mailing Address NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
RIEFLIN WILLIAM JL (Reporting) CIK: 0001182471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 221009164

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations